Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
-
Provides Patent Protection for AXS-02 into 2033Covers Uses of Oral Zoledronic Acid for Complex Regional Pain SyndromeRepresents the 19th Issued Patent Covering AXS-02 or Related Compounds NEW YORK,...